[
  {
    "ts": "2025-08-20T20:00:00+00:00",
    "headline": "Vertex to Participate in Upcoming September Investor Conferences",
    "summary": "BOSTON, August 20, 2025--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in three upcoming investor conferences.",
    "url": "https://finance.yahoo.com/news/vertex-participate-upcoming-september-investor-200000912.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "0deb29d8-71b7-3e55-9e5e-c9a1f2a63caf",
      "content": {
        "id": "0deb29d8-71b7-3e55-9e5e-c9a1f2a63caf",
        "contentType": "STORY",
        "title": "Vertex to Participate in Upcoming September Investor Conferences",
        "description": "",
        "summary": "BOSTON, August 20, 2025--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in three upcoming investor conferences.",
        "pubDate": "2025-08-20T20:00:00Z",
        "displayTime": "2025-08-20T20:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/ef00f906a423e0e6dcdb304e734baa24",
          "originalWidth": 480,
          "originalHeight": 252,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6zW.F4_yd2IdXqgLgRoYYA--~B/aD0yNTI7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/ef00f906a423e0e6dcdb304e734baa24.cf.webp",
              "width": 480,
              "height": 252,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5TRJUTqC2X.8Z2FU1sADsw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/ef00f906a423e0e6dcdb304e734baa24.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/vertex-participate-upcoming-september-investor-200000912.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/vertex-participate-upcoming-september-investor-200000912.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "VRTX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-08-20T08:14:00+00:00",
    "headline": "What's Wrong With Vertex Pharmaceuticals Stock?",
    "summary": "Shares of the pharma company are down 17% in the past 12 months.",
    "url": "https://www.fool.com/investing/2025/08/20/whats-wrong-with-vertex-pharmaceuticals-stock/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "c691d5fe-9e61-346c-b2d3-1dc327576b2c",
      "content": {
        "id": "c691d5fe-9e61-346c-b2d3-1dc327576b2c",
        "contentType": "STORY",
        "title": "What's Wrong With Vertex Pharmaceuticals Stock?",
        "description": "",
        "summary": "Shares of the pharma company are down 17% in the past 12 months.",
        "pubDate": "2025-08-20T08:14:00Z",
        "displayTime": "2025-08-20T08:14:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/0766de0a0023b5c1906358bc8eb269b3",
          "originalWidth": 1400,
          "originalHeight": 934,
          "caption": "Doctor discussing a report with people.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xk65SJpjbCMoswedkCNFkg--~B/aD05MzQ7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/0766de0a0023b5c1906358bc8eb269b3.cf.webp",
              "width": 1400,
              "height": 934,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/HZNESLk1tQGEX5.PSR26eQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/0766de0a0023b5c1906358bc8eb269b3.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/08/20/whats-wrong-with-vertex-pharmaceuticals-stock/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/whats-wrong-vertex-pharmaceuticals-stock-081400017.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "VRTX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]